View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 26, 2018

UK researchers develop new handheld diagnostic device

Researchers at the University of Glasgow in the UK have developed a new handheld diagnostic device comprising a sensor and a smartphone app.

Researchers at the University of Glasgow in the UK have developed a new handheld diagnostic device comprising a sensor and a smartphone app.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The device, which is part of the university’s multicorder project, is designed to measure different metabolite levels in fluid samples such as serum and urine from patients.

The measurement and tracking of metabolites is expected to help monitor general health and progression of certain diseases.

“The new handheld diagnostic device is based on a new form of complementary metal oxide semiconductor (CMOS) chip, which is used in imaging devices.”

The device can simultaneously detect and quantify several metabolite biomarkers. The team expects this functionality to aid in the effective treatment of heart attack, cancer and stroke which requires rapid diagnosis.

University of Glasgow School of Engineering research associate Samadhan Patil said: “We have been able to detect and measure multiple metabolites associated with myocardial infarction, or heart attack, and prostate cancer simultaneously using this device.

“This device has potential to track progression of the disease in its early phase and is ideally suited for the subsequent prognosis.”

Nuclear magnetic resonance and hyphenated mass spectrometry are commonly used to measure metabolites but are considered expensive and need bulky equipment.

To address such issues, the new handheld diagnostic device is based on a new form of complementary metal oxide semiconductor (CMOS) chip, which is used in imaging devices.

The chip is inexpensive, small and is divided into multiple reaction zones for allowing simultaneous detection and quantification of four metabolites.

University of Glasgow School of Life Sciences professor Mike Barrett said: “This new handheld device offers democratisation of metabolomics, which is otherwise confined within the laboratory, and offers low-cost alternative to study complex pathways in different diseases.”

The handheld diagnostic device can be operated through an Android-based tablet or smartphone that will offer data acquisition, computation, visualisation and power.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network